SARS-CoV-2 : PUB and Boxing stadium in Bangkok, Thailand

Authors

  • Pilailuk Akkapaiboon Okada National Institute of Health, Department of Medical Sciences
  • Siripaporn Phuygun National Institute of Health, Department of Medical Sciences
  • Sitthiporn Parnmen National Institute of Health, Department of Medical Sciences
  • Thanutsapa Thanadachakul National Institute of Health, Department of Medical Sciences
  • Sirichol Kala National Institute of Health, Department of Medical Sciences
  • Wandee Meechalard National Institute of Health, Department of Medical Sciences
  • Hathaikan Thanchai National Institute of Health, Department of Medical Sciences
  • Pakorn Piromtong National Institute of Health, Department of Medical Sciences
  • Warawan Wongboot National Institute of Health, Department of Medical Sciences
  • Ratana Tacharoenmuang National Institute of Health, Department of Medical Sciences
  • Sunthareeya Waicharoen National Institute of Health, Department of Medical Sciences
  • Malinee Chittaganpitch Medical Sciences Technical Office, Department of Medical Sciences
  • Ballang Uppapong National Institute of Health, Department of Medical Sciences
  • Opart Karnkawinpong Department of Medical Sciences

Keywords:

SARS-CoV-2, COVID-19, Phylogenetic analysis

Abstract

         The emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in Thailand was firstly confirmed on January 8, 2020 from the patient travelling from China, and the widespread infection of COVID-19, originally from a boxing stadium and pubs in Bangkok, has rapidly occurred in March. This study was to investigate the entire genome of SARS-CoV-2 from the two groups of patients with Thai nationality. Phylogenetic analysis was performed based on whole genome sequences of isolated SARS-CoV-2 derived from clinical samples of patients. Viral genotyping for both groups revealed that the virus infection was caused by clade S with a sister lineage to the strains from South Korea and Hong Kong and a basal lineage to the strains from Spain and Mexico. Our findings showed differences from clade L that was isolated from the Chinese patient during the initial COVID-19 outbreak in Thailand. It suggested that the genetic evolution of SARS-CoV-2 in Thailand was different from that in the epicenter of the outbreak in China.

References

World Health Organization. Naming the coronavirus disease (COVID-19) and the virus that causes it. [online]. 2020; [cited 2020 Mar 1]; [1 screen]. Available from: URL: https://www.who.int/emergencies/diseases/novel-coronavirus-2019/technical-guidance/naming-thecoronavirus-disease-(covid-2019)-and-the-virus-that-causes-it.

Okada P, Buathong R, Phuygun S, Thanadachakul T, Parnmen S, Wongboot W, el al. Early transmission patterns of coronavirus disease 2019 (COVID-19) in travellers from Wuhan to Thailand, January 2020. Euro Surveill 2020; 25(8): 2000097. (5 pages).

Tu YF, Chien CS, Yarmishyn AA, Lin YY, Luo YH, Lin YT, et al. A review of SARS-CoV-2 and the ongoing clinical trials. Int J Mol Sci 2020; 21(7): 2657. (19 pages).

มาลินี จิตตกานต์พิชย์. ปฐมบท COVID-19. ว กรมวิทย พ. [วารสารออนไลน์]. 2563; [สืบค้น 10 เมษายน 2563]; 62(1): [5 หน้า]. เข้าถึงได้จาก: URL: https://drive.google.com/file/d/1qcVr-2ekz0P-utd-D8EPqL5OjAdMPTPin/view.

Lu R, Zhao X, Li J, Niu P, Yang B, Wu H, et al. Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet 2020; 395(10224): 565-74.

Marra MA, Jones SJM, Astell CR, Holt RA, Brooks-Wilson A, Butterfield YSN, et. al. The genome sequence of the SARS-associated coronavirus. Science 2003; 300(5624): 1399-404.

Phan T. Genetic diversity and evolution of SARS-CoV-2. Infect Genet Evol 2020; 81: 104260. (3 pages).

GISAID. Clade and lineage nomenclature. [online]. 2020; [cited 2020 Mar 1]; [1 screen]. Available from: URL: https://www.gisaid.org/references/statements-clarifications/clade-and-lineagenomenclature-aids-in-genomic-epidemiology-of-active-hcov-19-viruses/

Miller MA, Pfeiffer W, Schwartz T. Creating the CIPRES science gateway for inference of large phylogenetic trees. [online]. 2010; [cited 2020 Apr 10]; [7 screens]. Available from: URL: https://www.phylo.org/sub_sections/portal/sc2010_paper.pdf.

Cleemput S, Dumon W, Fonseca V, Karim WA, Giovanetti M, Alcantara LC, et al. Genome detective coronavirus typing tool for rapid identification and characterization of novel coronavirus genomes. Bioinformatics 2020; 36(11): 3552-5.

Maurier F, Beury D, Fléchon L, Varré JS, Touzet H, Goffard A, et al. A complete protocol for whole-genome sequencing of virus from clinical samples: application to coronavirus OC43. Virology 2019; 531: 141-8.

Bartolini B, Rueca M, Gruber C, Messina F, Carletti F, Giombini E, et al. SARS-CoV-2 phylogenetic analysis, Lazio Region, Italy, February-March 2020. Emerg Infect Dis 2020; 26(8): 1842-5.

Mercatelli D, Giorgi FM. Geographic and genomic distribution of SARS-CoV-2 mutations. Front Microbiol 2020; 11: 1800. (13 pages).

Shah M, Ahmad B, Choi S, Woo HG. Sequence variation of SARS-CoV-2 spike protein may facilitate stronger interaction with ACE2 promoting high infectivity. Research Square. [online]. 2020; [cited 2020 Apr 10]; [21 screens]. Available from: URL: https://assets.researchsquare.com/files/rs-16932/v1/manuscript.pdf.

Brufsky A. Distinct viral clades of SARS-CoV-2: implications for modeling of viral spread. J Med Virol 2020; 92: 1386-90.

Oran DP, Topol EJ. Prevalence of asymptomatic SARS-CoV-2 infection a narrative review. Ann Intern Med 2020; 173(5): 362-7.

Downloads

Published

25-09-2020

How to Cite

1.
Akkapaiboon Okada P, Phuygun S, Parnmen S, Thanadachakul T, Kala S, Meechalard W, Thanchai H, Piromtong P, Wongboot W, Tacharoenmuang R, Waicharoen S, Chittaganpitch M, Uppapong B, Karnkawinpong O. SARS-CoV-2 : PUB and Boxing stadium in Bangkok, Thailand. ว กรมวิทย พ [internet]. 2020 Sep. 25 [cited 2025 Dec. 18];62(3):133-42. available from: https://he02.tci-thaijo.org/index.php/dmsc/article/view/245894

Issue

Section

Original Articles